Breakthrough T1D Clinical Trial Results Announced at the 55th EASD Meeting
A protein, called glucokinase (or GK), acts as a key regulator of sugar levels in the body. If blood glucose levels are deemed too high, activation of GK in the liver causes the body to use more glucose, which in turn lowers glucose levels in the blood. vTv Therapeutics has developed a GK activator, called […]
The Best of the Best: Researchers Unite at the 55th EASD Annual Meeting
For 55 years, leading researchers from around the world have gathered for the annual meeting of the European Association for the Study of Diabetes (EASD). At this year’s meeting, from September 16-20 in Barcelona, Spain, more than 50 studies will be presented by Breakthrough T1D researchers, funded now or in the past, working to find […]
FDA Approves Xeris Pharmaceuticals’ Glucagon to Treat Severe Hypoglycemia
On Tuesday, the type 1 diabetes (T1D) community got a helping hand in their ability to avoid severe hypoglycemia when the Food and Drug Administration (FDA) approved the first premixed, prefilled liquid glucagon formulation that can be used with either a pre-filled syringe (GVOKE PFS) or an auto-injector (GVOKE HypoPenTM). Xeris Pharmaceuticals, which created the […]
Breakthrough T1D Launches First Center of Excellence, Aiming to Accelerate Type 1 Diabetes Research
Breakthrough T1D today launched its first Center of Excellence, a new research and funding model aimed at accelerating leading type one diabetes (T1D) research. The new Breakthrough T1D Northern California Center of Excellence will unite the work being done at Stanford University and the University of California, San Francisco, focusing on beta cell therapies and […]
Semma Therapeutics, Backed by the T1D Fund, Acquired by Major Biopharma Company
In an exciting step forward in type 1 diabetes (T1D) research and development and for people with T1D, on September 3, 2019, Semma Therapeutics agreed to be acquired by Vertex for $950 million, the largest transaction ever in a T1D cure-based therapeutic program. The T1D Fund, Breakthrough T1D’s innovative venture philanthropy fund provided a catalytic […]
Breakthrough T1D Innovative Clinical Trial Design Workshop
BMC Medicine 16: 29 (2018)
Educators Align at the American Association of Diabetes Educators (AADE) Conference
Each year, diabetes educators from all over the world—including Nicole Johnson, DrPH, MPH, National Director, Breakthrough T1D Mission—gather for the annual meeting of the American Association of Diabetes Educators (AADE), which took place August 9-12 in Houston, Texas. The AADE’s aim is to drive optimal outcomes through integration of diabetes clinical management, self-management education, prevention, […]
The Type 1 Diabetes Digital Recipe Box
When you’re cooking to meet the needs of someone with type 1 diabetes (T1D), whether that be yourself, a family member or even a dinner guest, it can be challenging to find recipes that are healthy, carb-conscious, and tasty. That’s why we asked our Breakthrough T1D community to submit their go-to T1D-friendly recipes and kitchen […]
October 2019 Breakthrough T1D Young Adult Conference Speakers Announced
Breakthrough T1D’s Young Adult Conference is quickly approaching and we’re excited to announce our lineup of speakers! The event will be held in Orlando, Florida from October 12-13. Registration will remain open until September 30. In addition to networking and learning, you’ll have the opportunity to interact with our lineup of powerful speakers who are […]
Breakthrough T1D Hosts 3D Bioprinting Workshop for Type 1 Diabetes
Breakthrough T1D is committed to developing cell replacement therapies that will one day offer cures for type 1 diabetes (T1D). One goal is to explore technologies to recombine living cells, biomaterials, and molecular factors to create a functional pancreas. That’s why top researchers, engineers, clinicians, and industry experts in the field of 3D bioprinting recently […]
